Pharmacy Times

JUNE 11, 2025

Completion Date (Estimated): June 2027 “For people living with advanced ROS1+ lung cancer, who tend to be diagnosed at a younger age, having another treatment option can make a real difference for them and their loved ones,” Janet Freeman-Daily, cofounder and president of The ROS1ders, said in a news release.

FDA

European Pharmaceutical Review

NOVEMBER 18, 2024

These will be available for marketing from 2027, according to Sanofi. Supporting production of diabetes medicine Development of the Lyon Gerland site enables internal production of a drug for patients with preclinical type 1 diabetes, previously produced outside the EU and not by Sanofi.

Pharmaceutical Technology

JULY 1, 2025

The expansion will be concluded by late 2027, with production capacity increasing from 104 batches annually at peak utilisation to more than 240 batches. The expansion will introduce a new laboratory and advanced machinery such as a new filling line, two large size lyophilisers, a capping machine and an external vial washer.

Communication

The Checkup by Singlecare

JUNE 25, 2025

Medicare Part D beneficiaries may also save more on Breo Ellipta starting in 2027. For instance, Humana covers brand-name Breo Ellipta in its commercial insurance plans, Medicare Advantage prescription drug plans, and Medicare Part D plans , but some may have restrictions or require prior authorization. Can you get Breo Ellipta for free?

Insurance

Hospital Pharmacy Europe

JULY 21, 2025

of savings on its expected spending by 2027/28. ‘We have sought to keep proposed increases as low as possible, by using our reserves, and making savings.’ Increase in fitness to practise concerns Mr Rudkin added that the regulator was committed to making a further £1.5m

Insurance

DiversifyRx

JULY 16, 2025

100% Bonus Depreciation Extended Businesses can continue writing off the full cost of qualifying purchases (like equipment and vehicles) in the year they’re bought—through 2027. Small Business Tax Savings 7. Buy once, deduct all. Great for small businesses making smart investments in tools, tech, or trailers.

Insurance

Fierce Healthcare

OCTOBER 15, 2024

Walgreens reported a loss of $3 billion in the fourth quarter and plans to close 1,200 stores over the next three years as part of the retail drugstore chain's ongoing turnaround strategy amid a ro | Walgreens reported a loss of $3 billion in the fourth quarter and plans to close 1,200 stores over the next three years as part of the retail drugstore (..)

Pharmaceutical Technology

JULY 2, 2025

The merger, announced in April 2025 , will positively impact Merck’s financial position by contributing to revenues immediately, and is anticipated to be accretive to its earnings per share by 2027.

Packaging

The Checkup by Singlecare

JULY 11, 2025

The patent is expected to expire in 2027, so a generic version may become available in the years that follow. Trulicity assistance for Medicare patients When people are concerned about how much a drug costs , they often ask if there’s a generic version available for a reduced rate.

Insurance

PharmExec

AUGUST 13, 2025

The project aims to enhance AbbVie’s chemical synthesis capacity to support next-generation neuroscience, immunology, and oncology medicines, with construction beginning in 2025 and operations slated for 2027.

The Checkup by Singlecare

AUGUST 5, 2025

Lilly holds exclusive manufacturer rights for Trulicity until 2027 , when its U.S. Does Aetna cover generic Trulicity? Dulaglutide, the active ingredient in Trulicity, isn’t currently available as a generic. patent will expire. This means generic Trulicity won’t be manufactured for another two years or so.

Insurance

Pharmaceutical Technology

JULY 1, 2025

Takeda anticipates commencing commercialisation efforts for Gammagard liquid ERC in the US by 2026, with plans to follow suit in the European Union (EU) by 2027. GlobalData Strategic Intelligence US Tariffs are shifting - will you react or anticipate? Don’t let policy changes catch you off guard.

FDA

Pharmaceutical Technology

JULY 31, 2025

The company plans to begin clinical study in 2027. As per data presented at the 2025 European Conference on Obesity in May, Myo-4 normalised blood sugar levels in mice while reducing the loss of muscle and bone mass in comparison to semaglutide. We’ve got immense advantages over a GLP-1RA,” says Jon Rees, MitoRX CEO.

Packaging

STAT

DECEMBER 11, 2024

The company plans to begin the trial next year, with an eye toward regulatory filings in late 2027. Such a medicine, if proven effective, would be the closest thing to a vaccine the HIV field has produced in four decades of research. Read the rest…

Vaccines

Roots Analysis

JANUARY 27, 2025

Insights on Approved Subcutaneous Biologics Market Analysis Driven by the increased emphasis towards patient compliance and improved treatment outcome, the approved subcutaneous biologics market is anticipated to grow at an annualized growth rate of around 5%, till 2027.

Hospitals

The FDA Law Blog

JANUARY 29, 2025

Will he wait until the next PDUFA reauthorization in 2027 to instill additional changes at the agency? Kennedy has been critical of FDAs reliance on user fees to fund its mission. Will Kennedy try to overturn the user fee system thats been in place since 1992?

FDA

Pharmaceutical Technology

AUGUST 13, 2025

By GlobalData Learn more about Strategic Intelligence The construction on the new API facility in North Chicago is set to commence in autumn 2025, with the site fully operational by 2027. This development will enlarge AbbVie’s current manufacturing presence in the US.

Packaging

PharmExec

AUGUST 6, 2025

The announcement also detailed a plan to cut costs by $3 billion by 2027, with the expectation that the savings will be reinvested into developing sectors of the company. In late July, Merck announced plans to increase investments in US manufacturing and R&D capabilities.

Communication

STAT

DECEMBER 12, 2024

The company plans to begin the trial next year, with an eye toward regulatory filings in late 2027. Such a medicine, if proven effective, would be the closest thing to a vaccine the HIV field has produced in four decades of research.

Insurance

Pharmaceutical Technology

JULY 14, 2025

Member states of the organisation agreed earlier this year to pay 20% more in membership fees to stopgap the US funding shortfall, though WHO’s overall budget for 2026-2027 will be lower than that for 2024-2025. Sign up for our daily news round-up! Give your business an edge with our leading industry insights.

Vaccines

Pharmaceutical Technology

JUNE 26, 2025

The study, which is expected to produce initial results in the first half of 2027, will support potential approval in the US and Europe. By GlobalData Learn more about Strategic Intelligence RemeGen is conducting a global Phase III clinical trial with telitacicept for the treatment of generalised myasthenia gravis.

Packaging

Pharmaceutical Technology

JUNE 19, 2025

Then, we will need to run pre-clinical trials of these crystals, which will be in 2026 or 2027. Then the next step is to produce meaningful quantities of these crystals, which will be next year.” After that, it will be about compliance and regulation, as we must ensure that all our processes adhere to pharma regulations.

Communication

Pharmaceutical Technology

JULY 29, 2025

Merck & Co (MSD) has joined fellow big pharma companies in looking to redirect cash, as the drugmaker revealed plans to save $3bn annually by the end of 2027. Pfizer and BMS both have programmes set to save $1.5bn and $2bn, respectively, by 2027. Credit: HJBC via Shutterstock. Sign up for our daily news round-up!

Packaging

Pharmaceutical Technology

JULY 2, 2025

With the additional funds from Sanofi’s investment and current assets on hand, it anticipates sufficient funds to sustain its planned operations in 2027. As of December 2024, the company reported cash reserves of $85.2m.

Packaging

STAT

APRIL 21, 2025

The hulking factories are tucked away off the roads around the village of Ringaskiddy — operated by the likes of Pfizer, Johnson & Johnson, and BioMarin, whose plant featured signs last week touting a new facility “coming Q1 2027.”

Pharmaceutical Companies

STAT

JULY 31, 2025

billion by 2027. Moderna announced layoffs Thursday affecting 10% of its workforce, or more than 500 employees, as part of an ongoing effort to reduce operating costs amid government and competitive challenges to its vaccine business. 

Vaccines

PharmExec

AUGUST 1, 2025

Facing patent expiration for its blockbuster Keytruda, Merck aims to streamline operations with significant job cuts and continued R&D investments.

Pharmaceutical Technology

AUGUST 5, 2025

The company said it is on track to deliver $7.2bn in net savings by the end of 2027 as rising costs hit drugmakers across the US and Europe. Pfizer is one of many companies undergoing cost-saving strategies. Moderna, MSD, and BMS also all have billion-dollar cost-cutting programmes planned or underway.

Vaccines

PharmaVoice

JULY 28, 2025

Final results from these trials won’t be released until 2027 or 2028, although there will likely be some earlier signals from interim data. Both studies pit the drug directly against Keytruda, not a placebo as in the original trial. This will help answer the bigger question: Can it replace Keytruda?” Smith said.

Immunization

Pharmaceutical Technology

JULY 17, 2025

Find out more After its strategic review, the company aims to focus on high-impact programmes to meet its 2027 financial obligations and support long-term viability. This approach should maintain access to a $600m revolving credit facility while managing liabilities proactively, including repayment of convertible notes due in 2027.

Labelling

Drug Topics

JUNE 13, 2025

billion people used social media in 2021, and this number is likely to grow to almost 6 billion in 2027. “Social media browsing is the most popular online activity,” wrote authors of the study. According to the statistics, [over] 4.26 In April 2023, a total of 4.8 billion people, or 59.9% of the world’s population, were social media users.”

Specialty Pharmacies

Fierce Pharma

AUGUST 1, 2025

Word of the dismissals comes two days after Merck revealed a sweeping cost-cutting effort designed to save $3 billion annually by the end of 2027. Merck will reduce its workforce by approximately 6,000 employees in “some areas of our global workforce,” the New Jersey drugmaker told Fierce Pharma.

Pharmaceutical Technology

JUNE 25, 2025

The European Commission (EC) faces a March 2027 deadline to adopt several key implementing acts, which will lay out detailed rules for putting the regulation into practice. The regulation came into force in March 2025; however, it has not yet come into application, with this set to happen in March 2029.

Communication

pharmaphorum

JUNE 26, 2025

RemeGen already has approval in China for telitacicept as a treatment for generalised myasthenia gravis (gMG), systemic lupus erythematosus (SLE), and rheumatoid arthritis (RA), and has been advanced into a phase 3 trial in the US, Europe, and South America in gMG with results due in 2027.

Pharmaceutical Companies

PharmExec

AUGUST 1, 2025

billion in savings by 2027. Biotech firm aims to streamline operations and reinvest in high-growth areas such as oncology and rare diseases as it targets $1.5

Viseven

APRIL 15, 2025

billion by 2027. Streams, webinars, and other events can serve as a platform to invite other guests and leaders, both from the company and outside of it, to discuss hot topics and industry-related news that your customers and potential clients might be interested in. This means that every second person on the planet will use email services.

PharmTech

JULY 22, 2025

PMMI continues building long-term industry engagement, recognizing more than 100 companies from the original 1995 show and announcing five future Pack Expo events through 2027. 18–21, 2026; Pack Expo Southeast, in Atlanta from April 12–14, 2027; and Expo Pack Guadalajara, from June 15–17, 2027 (5). References 1. Press Release.

Dosage